See more : Acrow India Limited (ACROW.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Nanjing Vishee Medical Technology Co., Ltd (688580.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nanjing Vishee Medical Technology Co., Ltd, a leading company in the Medical – Devices industry within the Healthcare sector.
- China Power Equipment, Inc. (CPQQ) Income Statement Analysis – Financial Results
- Mo-BRUK S.A. (MBRFF) Income Statement Analysis – Financial Results
- China Carbon Neutral Development Group Limited (1372.HK) Income Statement Analysis – Financial Results
- Zhejiang Yayi Metal Technology Co.,Ltd (301113.SZ) Income Statement Analysis – Financial Results
- Credit Suisse High Yield Bond Fund, Inc. (DHY) Income Statement Analysis – Financial Results
Nanjing Vishee Medical Technology Co., Ltd (688580.SS)
About Nanjing Vishee Medical Technology Co., Ltd
Nanjing Vishee Medical Technology Co., Ltd. develops and manufactures medical rehabilitation devices in China. It offers pelvic floor and postpartum, neurological, and mental rehabilitation solutions; and bio-stimulation feedback devices, magnetic stimulators, etc. The company's solutions cover markets, such as electrical and magnetic stimulation, electrophysiology, and other technical directions. It offers its products through dealers, sales network, and distributors to hospitals, and terminal medical and professional institutions. The company was founded in 2001 and is based in Nanjing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 462.22M | 321.62M | 430.04M | 378.37M | 318.87M | 207.78M | 144.50M | 95.90M | 80.50M | 58.16M | 48.85M |
| Cost of Revenue | 130.51M | 88.52M | 108.45M | 99.76M | 83.82M | 53.68M | 37.88M | 25.55M | 21.89M | 17.34M | 15.32M |
| Gross Profit | 331.71M | 233.10M | 321.59M | 278.61M | 235.05M | 154.10M | 106.61M | 70.35M | 58.62M | 40.82M | 33.54M |
| Gross Profit Ratio | 71.76% | 72.48% | 74.78% | 73.63% | 73.71% | 74.17% | 73.78% | 73.36% | 72.81% | 70.18% | 68.65% |
| Research & Development | 57.65M | 43.73M | 63.52M | 34.29M | 27.38M | 18.54M | 13.04M | 8.99M | 0.00 | 0.00 | 1.82M |
| General & Administrative | 17.39M | 9.61M | 14.13M | 13.02M | 9.49M | 9.50M | 6.72M | 9.69M | 17.29M | 12.54M | 12.06M |
| Selling & Marketing | 123.64M | 91.54M | 78.10M | 72.05M | 75.13M | 53.17M | 41.93M | 32.06M | 16.24M | 14.30M | 14.02M |
| SG&A | 141.03M | 101.15M | 92.23M | 85.07M | 84.62M | 62.67M | 48.65M | 41.76M | 33.53M | 26.84M | 26.07M |
| Other Expenses | -15.41M | 18.00M | 7.40M | 13.05M | 11.85M | 3.72M | -504.64K | 6.59M | 0.00 | 5.40M | 7.18M |
| Operating Expenses | 183.27M | 162.88M | 163.15M | 132.40M | 123.85M | 84.93M | 61.19M | 52.08M | 30.57M | 27.81M | 26.72M |
| Cost & Expenses | 313.78M | 251.40M | 271.60M | 232.17M | 207.67M | 138.61M | 99.07M | 77.63M | 52.46M | 45.15M | 42.04M |
| Interest Income | 19.32M | 19.28M | 16.80M | 6.43M | 200.23K | 207.34K | 207.39K | 134.86K | 2.26M | 0.00 | 0.00 |
| Interest Expense | 1.32M | 334.05K | 184.70K | 412.76K | 887.49K | 611.75K | 33.51K | 28.27K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 21.98M | 18.82M | 11.46M | 8.99M | 8.06M | 4.03M | 1.04M | 690.04K | 843.76K | 673.52K | 581.80K |
| EBITDA | 173.32M | 125.00M | 209.07M | 175.54M | 123.80M | 78.04M | 47.81M | 18.96M | 24.69M | 13.68M | 7.40M |
| EBITDA Ratio | 37.50% | 38.55% | 48.72% | 46.52% | 38.81% | 37.47% | 32.48% | 19.90% | 30.66% | 19.56% | 15.99% |
| Operating Income | 148.44M | 104.46M | 194.68M | 164.86M | 114.67M | 72.02M | 46.85M | 20.34M | 23.84M | 17.15M | 7.72M |
| Operating Income Ratio | 32.11% | 32.48% | 45.27% | 43.57% | 35.96% | 34.66% | 32.42% | 21.21% | 29.62% | 29.48% | 15.80% |
| Total Other Income/Expenses | 1.57M | 1.38M | 2.70M | 1.22M | 124.25K | 1.34M | -111.20K | 6.59M | 3.62M | 5.40M | 7.18M |
| Income Before Tax | 150.01M | 105.84M | 197.38M | 166.08M | 114.80M | 73.36M | 46.74M | 26.93M | 30.31M | 22.55M | 14.89M |
| Income Before Tax Ratio | 32.45% | 32.91% | 45.90% | 43.89% | 36.00% | 35.31% | 32.35% | 28.08% | 37.65% | 38.76% | 30.48% |
| Income Tax Expense | 13.75M | 12.01M | 19.84M | 22.95M | 15.91M | 10.64M | 6.55M | 3.78M | 2.23M | 766.73K | 638.20K |
| Net Income | 136.26M | 93.83M | 177.81M | 143.66M | 99.72M | 63.36M | 40.34M | 23.15M | 28.13M | 21.75M | 13.99M |
| Net Income Ratio | 29.48% | 29.17% | 41.35% | 37.97% | 31.27% | 30.50% | 27.92% | 24.14% | 34.94% | 37.40% | 28.64% |
| EPS | 1.43 | 0.98 | 1.86 | 1.76 | 1.39 | 0.88 | 0.57 | 0.46 | 0.56 | 0.44 | 0.28 |
| EPS Diluted | 1.42 | 0.98 | 1.85 | 1.76 | 1.39 | 0.88 | 0.57 | 0.46 | 0.56 | 0.44 | 0.28 |
| Weighted Avg Shares Out | 95.53M | 95.66M | 95.96M | 81.73M | 71.77M | 71.65M | 71.03M | 50.00M | 50.23M | 49.43M | 49.43M |
| Weighted Avg Shares Out (Dil) | 95.68M | 95.66M | 95.96M | 81.73M | 71.77M | 71.65M | 71.03M | 50.00M | 50.23M | 49.43M | 49.43M |
Source: https://incomestatements.info
Category: Stock Reports